
|Articles|January 9, 2019
Elligo Health Research Acquires Protenium Clinical Research
Advertisement
Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research, an established research group led by Robert Strzinek, Ph.D., D.O. which conducts pharmaceutical studies in a broad range of therapeutic areas. The acquisition will bring the number of patients in Elligo’s Research Ready network to more than one million.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement